These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14741278)

  • 1. 3D-QSAR studies on PU3 analogues by comparative molecular field analysis.
    Liu HC; Lyu PC; Leong MK; Tsai KC; Hsiue GH
    Bioorg Med Chem Lett; 2004 Feb; 14(3):731-4. PubMed ID: 14741278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into designing the dual-targeted HER2/HSP90 inhibitors.
    Chen CY; Chen CY
    J Mol Graph Model; 2010 Aug; 29(1):21-31. PubMed ID: 20471294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysis.
    Gupta SP; Samanta S; Patil VM
    Med Chem; 2010 Mar; 6(2):87-90. PubMed ID: 20218964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the In-silico Design of New HSP90 Inhibitors: Molecular Docking and 3D-QSAR CoMFA Studies of Tetrahydropyrido [4, 3-d] Pyrimidine Derivatives as HSP90 Inhibitors.
    Sepehri B; Ghavami R
    Med Chem; 2018; 14(5):439-450. PubMed ID: 29564982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR Studies to Predict Activity of HSP90 Inhibitors.
    Patil VM; Masand N; Gupta SP; Blagg BSJ
    Curr Top Med Chem; 2021; 21(25):2272-2291. PubMed ID: 34635040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-QSAR studies on 4-hydroxyphenylpyruvate dioxygenase inhibitors by comparative molecular field analysis (CoMFA).
    Huang M; Yang DY; Shang Z; Zou J; Yu Q
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2271-5. PubMed ID: 12161114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, design and bio-evaluation of novel Hsp90 inhibitors by ligand-based virtual screening.
    Jia J; Xu X; Liu F; Guo X; Zhang M; Lu M; Xu L; Wei J; Zhu J; Zhang S; Zhang S; Sun H; You Q
    PLoS One; 2013; 8(4):e59315. PubMed ID: 23565147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.
    Bargiotti A; Musso L; Dallavalle S; Merlini L; Gallo G; Ciacci A; Giannini G; Cabri W; Penco S; Vesci L; Castorina M; Milazzo FM; Cervoni ML; Barbarino M; Pisano C; Giommarelli C; Zuco V; De Cesare M; Zunino F
    Eur J Med Chem; 2012 Jul; 53():64-75. PubMed ID: 22538015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
    Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
    Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
    Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular design of anticancer drug leads based on three-dimensional quantitative structure-activity relationship.
    Huang XY; Shan ZJ; Zhai HL; Li LN; Zhang XY
    J Chem Inf Model; 2011 Aug; 51(8):1999-2006. PubMed ID: 21755987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
    Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of semisynthetic analogues and 3D-QSAR study of eunicellin-based diterpenoids as prostate cancer migration and invasion inhibitors.
    Hassan HM; Elnagar AY; Khanfar MA; Sallam AA; Mohammed R; Shaala LA; Youssef DT; Hifnawy MS; El Sayed KA
    Eur J Med Chem; 2011 Apr; 46(4):1122-30. PubMed ID: 21334794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N; Lecanu L; Greeson J; Papadopoulos V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antiproliferative activity of C5-benzyl substituted 2-amino-pyrrolo[2,3-d]pyrimidines as potent Hsp90 inhibitors.
    Lee JH; Shin SC; Seo SH; Seo YH; Jeong N; Kim CW; Kim EE; Keum G
    Bioorg Med Chem Lett; 2017 Jan; 27(2):237-241. PubMed ID: 27914802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors.
    Sekhar YN; Nayana MR; Sivakumari N; Ravikumar M; Mahmood SK
    J Mol Graph Model; 2008 Jun; 26(8):1338-52. PubMed ID: 18372201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors.
    Saxena S; Chaudhaery SS; Varshney K; Saxena AK
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):445-62. PubMed ID: 20818581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.